Company intelligence / Profile preview

Beijing Digital Precision Medicine Technology

Beijing, Beijing, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

DPM’s fluorescent molecular imaging systems enable precise intraoperative navigation, outperforming conventional methods for sentinel lymph node detection; products recognized as innovative by regulators, with clinical improvements in breast cancer surgery outcomes

Therapeutic areas: Oncology
Modalities: DeviceMolecular imaging agent
Industry: Medical Imaging

Partnerships

Johnson & Johnson Medical Technology

Beyond the preview

Go deeper on Beijing Digital Precision Medicine Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Digital Precision Medicine Technology.

Explore the full profile